{"nct_id":"NCT01362140","title":"Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2011-12-21","start_date_type":"ACTUAL","primary_completion_date":"2015-02-11","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}